Nisa Investment Advisors LLC decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,133 shares of the company’s stock after selling 50 shares during the period. Nisa Investment Advisors LLC’s holdings in Thermo Fisher Scientific were worth $23,880,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Emerald Acquisition Ltd. bought a new position in shares of Thermo Fisher Scientific during the second quarter valued at approximately $200,618,000. Sound Shore Management Inc. CT raised its position in shares of Thermo Fisher Scientific by 123.5% in the second quarter. Sound Shore Management Inc. CT now owns 2,204,253 shares of the company’s stock valued at $138,096,000 after buying an additional 1,217,950 shares in the last quarter. FMR LLC raised its position in shares of Thermo Fisher Scientific by 11.3% in the second quarter. FMR LLC now owns 8,216,645 shares of the company’s stock valued at $1,214,093,000 after buying an additional 834,858 shares in the last quarter. Carmignac Gestion raised its position in shares of Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock valued at $597,918,000 after buying an additional 763,421 shares in the last quarter. Finally, Janus Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 50.5% in the second quarter. Janus Capital Management LLC now owns 1,972,203 shares of the company’s stock valued at $291,410,000 after buying an additional 661,475 shares in the last quarter. Hedge funds and other institutional investors own 86.28% of the company’s stock.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 3.09% during mid-day trading on Monday, reaching $139.72. The company had a trading volume of 2,291,690 shares. The firm has a market capitalization of $55.19 billion, a P/E ratio of 27.93 and a beta of 1.24. The stock’s 50-day moving average is $149.80 and its 200 day moving average is $151.93. Thermo Fisher Scientific Inc. has a 12 month low of $119.75 and a 12 month high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Thursday, October 27th. The company reported $2.03 EPS for the quarter, topping the Zacks’ consensus estimate of $1.97 by $0.06. The firm earned $4.49 billion during the quarter, compared to the consensus estimate of $4.39 billion. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. The firm’s revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.80 EPS. On average, analysts predict that Thermo Fisher Scientific Inc. will post $8.25 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 16th. Investors of record on Thursday, December 15th will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, December 13th. This represents a $0.60 dividend on an annualized basis and a yield of 0.42%. Thermo Fisher Scientific’s payout ratio is currently 12.00%.

COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2016/11/28/nisa-investment-advisors-llc-sells-50-shares-of-thermo-fisher-scientific-inc-tmo.html.

Several equities analysts have commented on the stock. Jefferies Group reiterated a “hold” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 4th. JPMorgan Chase & Co. assumed coverage on shares of Thermo Fisher Scientific in a research note on Thursday, September 22nd. They issued an “overweight” rating and a $180.00 price target on the stock. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Leerink Swann assumed coverage on shares of Thermo Fisher Scientific in a research report on Thursday, November 10th. They set an “outperform” rating and a $175.00 target price on the stock. Finally, Bank of America Corp. set a $180.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Friday, October 7th. Two analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Thermo Fisher Scientific has a consensus rating of “Buy” and an average target price of $164.37.

In other news, CEO Marc N. Casper sold 30,000 shares of the stock in a transaction on Thursday, September 1st. The stock was sold at an average price of $151.17, for a total value of $4,535,100.00. Following the completion of the transaction, the chief executive officer now owns 308,647 shares of the company’s stock, valued at $46,658,166.99. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 28,797 shares of the stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $151.01, for a total value of $4,348,634.97. Following the completion of the transaction, the chief executive officer now directly owns 307,444 shares of the company’s stock, valued at approximately $46,427,118.44. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.